Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast

Breast J. 2019 Jan;25(1):175-176. doi: 10.1111/tbj.13187. Epub 2018 Dec 18.

Authors

Semir Vranic^{1

2

3}, Juan Palazzo⁴, Jeffrey Swensen⁵, Joanne Xiu⁵, Elena Florento⁵, Zoran Gatalica⁵

Affiliations

¹ Department of Pathology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
² School of Medicine, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
³ College of Medicine, Qatar University, Doha, Qatar.
⁴ Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
⁵ Caris Life Sciences, Phoenix, Arizona.

No abstract available

MeSH terms

B7-H1 Antigen / genetics
Biomarkers, Tumor / genetics
Breast Neoplasms / genetics*
Breast Neoplasms / pathology
Carcinoma, Ductal, Breast / genetics*
Carcinoma, Ductal, Breast / pathology
DNA Copy Number Variations
Female
Gene Expression Regulation, Neoplastic
Humans
Microsatellite Instability
Mutation
Theranostic Nanomedicine / methods

Substances

B7-H1 Antigen
Biomarkers, Tumor
CD274 protein, human